Trivitron, the largest medical technology provider of Indian origin has today announced its joint venture with ET Medical Devices, Italy to manufacture and market advanced technology cardiac diagnostic instruments which includes ECG systems, Stress Test ECG, Holter ECG, ABPM recording units, Monitoring systems and Telemedicine IT Solutions. Through this tie-up, ET Medical Devices will manufacture and market Cardiac Diagnostics instruments by setting up its manufacturing facility at Trivitron’s Medical Technology Park in Chennai, India. Located in Italy, ET Medical Devices SpA is a provider of innovative diagnostic cardiovascular technology branded CARDIETTE – CARDIOLINE .CARDIETTE-CARDIOLINE expertise is in cardiac diagnostics instruments with a strong reputation for innovation and design. With over 50 years rich experience and market understanding, the company is committed to cardiac instruments technology.
The JV will be named ET Trivitron Medical Technologies and it will promote the solutions under the global recognized brand CARDIETTE – CARDIOLINE said Mr. Attilio Castelli, Managing Director & CEO, ET Medical Devices SPA, Italy. They have been present in Indian market distributing products through BPL since 1997. Over 20,000 units of various products have been sold with major share being from ECG recorders. Mr. Castelli said with India becoming the most favourite destination in the world for healthcare, matching its infrastructure and technology with those in USA, UK & Europe, we decided to expand our operations by setting up a manufacturing and distribution operation. We have identified Trivitron which has created the first-of-its-kind, world class medical technology park in Chennai, India. This will be the first facility in India for the manufacturing of the most advanced cardiac diagnostic instruments and production of the same is expected to commence by the end of FY 2010-2011.”
Commenting on the JV, Dr. G.S.K. Velu, Managing Director, Trivitron, said that we are happy to be associated with ET Medical Devices. Our focus in setting up a medical technology park in India is to manufacture medical equipments in the areas of cardiac care, critical care, imaging, operation theatres, renal care, implantable medical devices and laboratory diagnostics. The objective is to manufacture quality and cost-effective medical technology products suited to the needs of emerging countries. As these products, once manufactured in India, would be at least 30 to 40 per cent cheaper than imported and even hospitals or institutions in rural areas of the country would be able to afford. Added Dr.Velu, India being the capital of world diabetes and cardiovascular diseases, increased awareness and quality healthcare providers, there is an increased demand for cardiac diagnostic instruments like ECG machines, Holter systems etc. The manufacturing facility we are creating will be one of the largest facility in Asia catering to all the emerging markets and to the world eventually.